Biotechnology - Woburn, Massachusetts, United States
ConsortiaTX is an early stage, microbiome therapeutics company developing CTX-944, a first-in-kind live microbial therapeutic to reverse pre-existing food allergy. CTX-944 is designed to be a safe, allergen-independent orally-delivered treatment of food allergies. ConsortiaTX was founded on the ground-breaking science of Harvard Medical School scientists Lynn Bry, Talal Chatila and Georg Gerber, and represents their collective decades of experience studying food allergy and the microbiome.
Gmail
Cloudflare DNS
Google Apps
CloudFlare Hosting